Skip to main content

View full-text article in PMC

. 2016 Jun 27;12(3):1251–1262. doi: 10.3892/etm.2016.3485

Table IV.

Alterations in bone mineral contents.

				Polycan-treated groups

Bone	Sham control	OVX control	Alendronate	31.25 mg/kg	62.5 mg/kg	125 mg/kg
Femur
Ca mg/g bone	170.86±13.75	95.82±17.78^a	120.95±12.40^a,b	106.05±14.02^c	125.12±9.03^a,b	138.07±16.11^a,b
P mg/g bone	98.71±7.56	57.29±11.04^a	73.60±13.18^a,b	63.19±9.20^c	76.48±11.47^a,d	83.30±10.28^c,d
Ca/P ratio	1.74±0.16	1.70±0.34	1.69±0.34	1.70±0.28	1.67±0.29	1.68±0.29
Tibia
Ca mg/g bone	196.13±9.74	103.82±15.02^a	133.37±21.61^a,d	110.14±14.66^c	128.77±10.45^a,d	140.72±15.00^a,d
P mg/g bone	99.66±11.83	52.67±7.66^a	67.93±7.47^a,d	55.54±6.04^c	67.11±6.52^a,d	70.00±7.12^a,d
Ca/P ratio	1.99±0.22	1.99±0.31	1.99±0.42	2.00±0.31	1.93±0.17	2.03±0.28
L₄
Ca mg/g bone	210.14±8.35^a	124.41±12.48^a	138.50±9.19^a	138.10±13.87^c	146.84±16.78^a,b	155.79±11.09^a,d
P mg/g bone	113.50±13.77^a	66.91±8.53^a	74.12±7.24^a	75.61±12.46^c	78.77±10.05^a,b	83.25±6.81^a,d
Ca/P ratio	1.87±0.23	1.90±0.45	1.88±0.20	1.87±0.38	1.88±0.23	1.88±0.16

Data are presented as the mean ± standard deviation of 8 rats.

^a

P<0.01

^c

P<0.05 vs. sham control group.

^b

P<0.05

^d

P<0.01 vs. OVX control group. OVX, ovariectomized; L₄, 4th lumbar vertebrae.